Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biosci Rep
2020 May 29;405:. doi: 10.1042/BSR20191227.
Show Gene links
Show Anatomy links
Cell division cycle proteinising prognostic biomarker of breast cancer.
Cheng L
,
Huang YZ
,
Chen WX
,
Shi L
,
Li Z
,
Zhang X
,
Dai XY
,
Wei JF
,
Ding Q
.
???displayArticle.abstract???
Cell division cycle protein (CDC20) has been observed to be expressed higher in various kinds of human cancers and was associated with poor prognosis. However, studies on role of CDC20 in breast cancer are seldom reported till now, most of which are not systematic and conclusive. The present study was performed to analyze the expression pattern, potential function, and distinct prognostic effect of CDC20 in breast cancer using several online databases including Oncomine, bc-GenExMiner, PrognoScan, and UCSC Xena. To verify the results from databases, we compared the mRNA CDC20 expression in breast cancer tissues and adjacent normal tissues of patients by real-time PCR. We found that CDC20 was expressed higher in different types of breast cancer, comparing with normal tissues. Moreover, the patients with a more advanced stage of breast cancer tended to express higher level CDC20. CDC20 was expressed higher in breast cancer tissues than normal tissues from patients in our hospital, consistent with the results from databases. Estrogen receptor (ER) and progesterone receptor (PR) status were negatively correlated with CDC20 level. Conversely, Scarff-Bloom-Richardson (SBR) grade, Nottingham prognostic index (NPI), epidermal growth factor receptor-2 (HER-2) status, basal-like status, and triple-negative status were positively related to CDC20 expression in breast cancer patients with respect to normal individuals. Higher CDC20 expression correlated with worse survival. Finally, a positive correlation between CDC20 and Targeting protein for Xenopus kinesin-like protein 2 (TPX2) expression was revealed. CDC20 could be considered as a potential predictive indicator for prognosis of breast cancer with co-expressed TPX2 gene.
Bagaria,
Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.
2014, Pubmed
Bagaria,
Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.
2014,
Pubmed
Bansal,
Grading systems in the cytological diagnosis of breast cancer: a review.
2014,
Pubmed
Casper,
The UCSC Genome Browser database: 2018 update.
2018,
Pubmed
Chandrashekar,
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
2017,
Pubmed
Chang,
Atomic structure of the APC/C and its mechanism of protein ubiquitination.
2015,
Pubmed
Chang,
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
2012,
Pubmed
Choi,
High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer.
2013,
Pubmed
Ding,
Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
2014,
Pubmed
Duffy,
Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
2015,
Pubmed
Fan,
Breast cancer in China.
2014,
Pubmed
Jézéquel,
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
2012,
Pubmed
Jézéquel,
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
2013,
Pubmed
Karra,
Cdc20 and securin overexpression predict short-term breast cancer survival.
2014,
Pubmed
Kato,
Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients.
2012,
Pubmed
Kim,
MAD2 and CDC20 are upregulated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
2014,
Pubmed
Lee,
The Nottingham prognostic index for invasive carcinoma of the breast.
2008,
Pubmed
Liang,
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
2015,
Pubmed
Ma,
Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
2006,
Pubmed
Marucci,
Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
2008,
Pubmed
Mizuno,
PrognoScan: a new database for meta-analysis of the prognostic value of genes.
2009,
Pubmed
Moura,
High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
2014,
Pubmed
Neumayer,
TPX2: of spindle assembly, DNA damage response, and cancer.
2014,
Pubmed
Neumayer,
TPX2 impacts acetylation of histone H4 at lysine 16: implications for DNA damage response.
2014,
Pubmed
Rennstam,
Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
2001,
Pubmed
Rhodes,
ONCOMINE: a cancer microarray database and integrated data-mining platform.
2004,
Pubmed
Smolders,
Targeting the anaphase promoting complex: common pathways for viral infection and cancer therapy.
2011,
Pubmed
Tomii,
TPX2 expression is associated with poor survival in gastric cancer.
2017,
Pubmed
,
Xenbase
Wei,
TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
2013,
Pubmed
Weinstein,
A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4.
1994,
Pubmed
Wu,
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.
2013,
Pubmed
Yu,
Cdc20: a WD40 activator for a cell cycle degradation machine.
2007,
Pubmed
Yuan,
Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
2006,
Pubmed
Zhang,
Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
2018,
Pubmed
